These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 25835212)
1. Controlled and Extended Release of a Model Protein from a Microsphere-Hydrogel Drug Delivery System. Osswald CR; Kang-Mieler JJ Ann Biomed Eng; 2015 Nov; 43(11):2609-17. PubMed ID: 25835212 [TBL] [Abstract][Full Text] [Related]
2. Controlled and Extended In Vitro Release of Bioactive Anti-Vascular Endothelial Growth Factors from a Microsphere-Hydrogel Drug Delivery System. Osswald CR; Kang-Mieler JJ Curr Eye Res; 2016 Sep; 41(9):1216-22. PubMed ID: 26764892 [TBL] [Abstract][Full Text] [Related]
3. An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease. Xie B; Jin L; Luo Z; Yu J; Shi S; Zhang Z; Shen M; Chen H; Li X; Song Z Int J Pharm; 2015 Jul; 490(1-2):375-83. PubMed ID: 26027491 [TBL] [Abstract][Full Text] [Related]
4. Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Controlled and Extended Release of Bioactive Aflibercept In Vitro. Liu W; Lee BS; Mieler WF; Kang-Mieler JJ Curr Eye Res; 2019 Mar; 44(3):264-274. PubMed ID: 30295090 [TBL] [Abstract][Full Text] [Related]
5. Fabrication and characterization of a smart drug delivery system: microsphere in hydrogel. Zhang XZ; Jo Lewis P; Chu CC Biomaterials; 2005 Jun; 26(16):3299-309. PubMed ID: 15603825 [TBL] [Abstract][Full Text] [Related]
6. In vitro characterization of vascular endothelial growth factor and dexamethasone releasing hydrogels for implantable probe coatings. Norton LW; Tegnell E; Toporek SS; Reichert WM Biomaterials; 2005 Jun; 26(16):3285-97. PubMed ID: 15603824 [TBL] [Abstract][Full Text] [Related]
7. Hydrogel-PLGA delivery system prolongs 2-methoxyestradiol-mediated anti-tumor effects in osteosarcoma cells. Maran A; Dadsetan M; Buenz CM; Shogren KL; Lu L; Yaszemski MJ J Biomed Mater Res A; 2013 Sep; 101(9):2491-9. PubMed ID: 23355512 [TBL] [Abstract][Full Text] [Related]
8. Zero order controlled release delivery of cholecalciferol from injectable biodegradable microsphere: In-vitro characterization and in-vivo pharmacokinetic studies. Vora L; V G S; Vavia P Eur J Pharm Sci; 2017 Sep; 107():78-86. PubMed ID: 28629804 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of poly(lactic acid-co-glycolic acid) complex microspheres as drug carriers. Wang F; Liu X; Yuan J; Yang S; Li Y; Gao Q J Biomater Appl; 2016 Oct; 31(4):544-552. PubMed ID: 27368752 [TBL] [Abstract][Full Text] [Related]
10. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival. Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818 [TBL] [Abstract][Full Text] [Related]
11. Poly(ethylene glycol)-poly(lactic-co-glycolic acid) core-shell microspheres with enhanced controllability of drug encapsulation and release rate. Cha C; Jeong JH; Kong H J Biomater Sci Polym Ed; 2015; 26(13):828-40. PubMed ID: 26063500 [TBL] [Abstract][Full Text] [Related]
12. Microsphere-integrated drug-eluting stents: PLGA microsphere integration in hydrogel coating for local and prolonged delivery of hydrophilic antirestenosis agents. Indolfi L; Causa F; Giovino C; Ungaro F; Quaglia F; Netti PA J Biomed Mater Res A; 2011 May; 97(2):201-11. PubMed ID: 21394898 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of PEGylated exendin-4 released from poly (lactic-co-glycolic acid) microspheres for antidiabetic therapy. Lim SM; Eom HN; Jiang HH; Sohn M; Lee KC J Pharm Sci; 2015 Jan; 104(1):72-80. PubMed ID: 25407390 [TBL] [Abstract][Full Text] [Related]
14. In Vivo Efficacy of an Injectable Microsphere-Hydrogel Ocular Drug Delivery System. Osswald CR; Guthrie MJ; Avila A; Valio JA; Mieler WF; Kang-Mieler JJ Curr Eye Res; 2017 Sep; 42(9):1293-1301. PubMed ID: 28557571 [TBL] [Abstract][Full Text] [Related]
15. Injectable microsphere/hydrogel combination systems for localized protein delivery. Lee J; Lee KY Macromol Biosci; 2009 Jul; 9(7):671-6. PubMed ID: 19226561 [TBL] [Abstract][Full Text] [Related]
16. Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administration. Rodríguez Villanueva J; Bravo-Osuna I; Herrero-Vanrell R; Molina Martínez IT; Guzmán Navarro M Eur J Pharm Sci; 2016 Sep; 92():287-97. PubMed ID: 26987610 [TBL] [Abstract][Full Text] [Related]
17. Controlled delivery of antibodies from injectable hydrogels. Fletcher NA; Babcock LR; Murray EA; Krebs MD Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():801-806. PubMed ID: 26652435 [TBL] [Abstract][Full Text] [Related]
18. A mesoporous silicon/poly-(DL-lactic-co-glycolic) acid microsphere for long time anti-tuberculosis drug delivery. Xu W; Wei X; Wei K; Cao X; Zhong S Int J Pharm; 2014 Dec; 476(1-2):116-23. PubMed ID: 25271077 [TBL] [Abstract][Full Text] [Related]
19. A potential approach for decreasing the burst effect of protein from PLGA microspheres. Fu K; Harrell R; Zinski K; Um C; Jaklenec A; Frazier J; Lotan N; Burke P; Klibanov AM; Langer R J Pharm Sci; 2003 Aug; 92(8):1582-91. PubMed ID: 12884245 [TBL] [Abstract][Full Text] [Related]
20. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]